Menu
Microsoft strongly encourages users to switch to a different browser than Internet Explorer as it no longer meets modern web and security standards. Therefore we cannot guarantee that our site fully works in Internet Explorer. You can use Chrome or Firefox instead.

Medpace Holdings Inc buy melinda

Start price
€26.02
08.03.17 / 50%
Target price
€32.47
04.04.17
Performance (%)
4.44%
End price
€27.18
04.04.17
Summary
This prediction ended on 04.04.17 with a price of €27.18. With a performance of 4.44%, the BUY prediction by melinda for Medpace Holdings Inc closed with a slight gain. melinda has 50% into this prediction
Performance without dividends (%)
Name 1w 1m 1y 3y
Medpace Holdings Inc -0.360% -0.360% 90.986% 161.014%
iShares Core DAX® -0.205% 2.949% 17.330% 18.203%
iShares Nasdaq 100 1.613% 5.877% 37.451% 56.281%
iShares Nikkei 225® -0.740% -1.256% 11.847% 5.531%
iShares S&P 500 0.267% 3.240% 29.308% 46.371%

According to melinda what are the pros and cons of Medpace Holdings Inc for the foreseeable future?

Pros
Could be worthwhile Investment >10% per year
Cons

Comments by melinda for this prediction

In the thread Medpace Holdings Inc diskutieren
Prediction Buy
Perf. (%) 4.44%
Target price 32.472
Change
Ends at 04.04.17

medizinische Geräte



Medpace Holdings, Inc. engagiert in der Forschung, Entwicklung und Handel von Medizinprodukten und pharmazeutischen products.Its Dienstleistungen umfassen klinische Operationen, Medical Writing und Überprüfung, Biometrie, Pharmakovigilanz, Imaging - Kernlabor, klinische Pharmakologie, Interactive Voice Response System


Prediction Buy
Perf. (%) 4.44%
Target price 32.472
Change
Ends at 04.04.17

(Vom Mitglied beendet)

Stopped prediction by melinda for Medpace Holdings Inc

Medpace Holdings Inc

Start price
Target price
Perf. (%)
€218.90
25.10.22
€190.00
25.10.23
11.47%
26.10.23

Could be worthwhile Investment >10% per year
buy
Medpace Holdings Inc

Start price
Target price
Perf. (%)
€91.00
24.09.20
€145.00
04.11.21
114.29%
05.11.21

Could be worthwhile Investment >10% per year